Profile

PhD, University of Wisconsin-Madison
MS, University of Missouri


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Chiang KC, Yeh CN, Pang JH, Hsu JT, Yeh TS, Chen LW, Kuo SF, Hsieh PJ, Pan YC, Takano M, Chen TC, Feng TH, Kittaka A, Juang HH. 1a,25(OH)2D3 Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Growth Through Induction of G0/G1 Cell-cycle Arrest and Apoptosis. Anticancer Res. 2016 Jul; 36(7):3307-13. PMID: 27354587.
     
  2. Yang SW, Tsai CY, Pan YC, Yeh CN, Pang JH, Takano M, Kittaka A, Juang HH, Chen TC, Chiang KC. MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells. Drug Des Devel Ther. 2016; 10:1995-2002. PMID: 27382252; PMCID: PMC4918737; DOI: 10.2147/DDDT.S107256;.
     
  3. Chiang KC, Yeh TS, Chen SC, Pang JH, Yeh CN, Hsu JT, Chen LW, Kuo SF, Takano M, Kittaka A, Chen TC, Sun CC, Juang HH. The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential. Int J Mol Sci. 2016 Apr 21; 17(4). PMID: 27110769; PMCID: PMC4849057; DOI: 10.3390/ijms17040606;.
     
  4. Munetsuna E, Kittaka A, Chen TC, Sakaki T. Metabolism and Action of 25-Hydroxy-19-nor-Vitamin D3 in Human Prostate Cells. Vitam Horm. 2016; 100:357-77. PMID: 26827959; DOI: 10.1016/bs.vh.2015.10.009;.
     
  5. Chiang KC, Sun CC, Chen MH, Huang CY, Hsu JT, Yeh TS, Chen LW, Kuo SF, Juang HH, Takano M, Kittaka A, Chen TC, Yeh CN, Pang JH. MART-10, the new brand of 1a,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro. J Steroid Biochem Mol Biol. 2016 Jan; 155(Pt A):26-34. PMID: 26385607; DOI: 10.1016/j.jsbmb.2015.09.022;.
     
  6. Chiang KC, Kuo SF, Chen CH, Ng S, Lin SF, Yeh CN, Chen LW, Takano M, Chen TC, Juang HH, Kittaka A, Lin JD, Pang JH. MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential. Cancer Lett. 2015 Dec 1; 369(1):76-85. PMID: 26282787; DOI: 10.1016/j.canlet.2015.07.024;.
     
  7. Chiang KC, Yen CL, Yeh CN, Hsu JT, Chen LW, Kuo SF, Wang SY, Sun CC, Kittaka A, Chen TC, Yeh TS, Hsu SY, Juang HH. Hepatocellular carcinoma cells express 25(OH)D-1a-hydroxylase and are able to convert 25(OH)D to 1a,25(OH)2D, leading to the 25(OH)D-induced growth inhibition. J Steroid Biochem Mol Biol. 2015 Nov; 154:47-52. PMID: 26170242; DOI: 10.1016/j.jsbmb.2015.06.008;.
     
  8. Kaess BM, Preis SR, Lieb W, Beiser AS, Yang Q, Chen TC, Hengstenberg C, Erdmann J, Schunkert H, Seshadri S, Vasan RS, Assimes TL, Deloukas P, Holm H, Kathiresan S, König IR, McPherson R, Reilly MP, Roberts R, Samani NJ, Stewart AF. Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community. J Am Heart Assoc. 2015 Mar; 4(3):e001544.View Related Profiles. PMID: 25762803; PMCID: PMC4392437; DOI: 10.1161/JAHA.114.001544;.
     
  9. Matsumoto Y, Kittaka A, Chen TC. 19-Norvitamin D analogs for breast cancer therapy. Can J Physiol Pharmacol. 2015 May; 93(5):333-48. PMID: 25918960; DOI: 10.1139/cjpp-2014-0452;.
     
  10. Takano M, Sawada D, Yasuda K, Nishikawa M, Takeuchi A, Takagi K, Horie K, Reddy GS, Chen TC, Sakaki T, Kittaka A. Synthesis and metabolic studies of 1a,2a,25-, 1a,4a,25- and 1a,4ß,25-trihydroxyvitamin D3. J Steroid Biochem Mol Biol. 2015 Apr; 148:34-7. PMID: 25263656; DOI: 10.1016/j.jsbmb.2014.09.021;.
     
Showing 10 of 254 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 53 publications over 17 distinct years, with a maximum of 14 publications in 1998

YearPublications
19801
19913
19924
19931
19942
19958
19961
19972
199814
20001
20019
20052
20061
20091
20101
20111
20121
Contact for Mentoring: